AARD•benzinga•
B of A Securities Maintains Buy on Aardvark Therapeutics, Raises Price Target to $26
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 27, 2025 by benzinga